Note: This mechanism is for AIDS-related & non AIDS-related research.
Please check Submission Requirements below, as deadlines vary accordingly.
A total of five institutes and centres of the National Institutes of Health invite applications for developing the therapeutic potential of the endocannabinoid system for pain treatment (R01 clinical trial optional). This supports projects that seek to elucidate the therapeutic potential of the cannabinoids and endocannabinoid system in the development of mechanism-based therapies for pain. The goal is to understand the role of cannabinoids in the management of chronic pain, in part, to help mitigate the high rate of use and abuse of opioids.
Funding & Duration
The number of awards is contingent upon NIH appropriations and the submission of a sufficient number of meritorious applications. Application budgets are not limited but need to reflect the actual needs of the proposed project. The maximum project period is five years.
US and foreign for-profit and non-profit organisations and public and private organisations are eligible to apply.
Submission Requirements & Due Date
- Aids-related applications must be submitted for internal review by 21 December 2018
- All other applications must be submitted for internal review by 22 January 2019
- Please email firstname.lastname@example.org if you are considering applying for this scheme.
- See also: Submitting an Application to Research Services for Review